Palonosetron Suppliers & Bulk Manufacturers
Available Forms: IV Injection
Available Strengths: 0.25 mg/5 mL (0.05 mg/mL)
Reference Brands: Aloxi® (US & EU)
Category: Oncology Cancer Care
Palonosetron is available in IV Injection and strengths such as 0.25 mg/5 mL (0.05 mg/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Palonosetron is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Palonosetron can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Palonosetron Injection is a next-generation 5-HT3 receptor antagonist used to prevent chemotherapy-induced and post-operative nausea and vomiting (CINV & PONV). Known for its long half-life and superior efficacy, Palonosetron provides extended protection against both acute and delayed emesis. It is available in 0.25 mg/5 mL and 0.075 mg/mL IV formulations, ideal for hospital and oncology settings. Marketed under Aloxi® in the US and EU, and also offered in generic form, it is manufactured under GMP-certified conditions. Palonosetron is a preferred antiemetic for pharmaceutical distributors seeking reliable oncology support across Europe and North America.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Crinecerfont
Strength:
50 mg, 100 mg, 50 mg/mL
Form: Capsule / Oral solution
Reference Brands: Crenessity (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
